View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Techstore Berhad: 3 directors

Three Directors at Techstore Berhad sold/bought 580,000 shares at between 0.250MYR and 0.255MYR. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...

Star Bulk Carriers Corp: 1 director

A director at Star Bulk Carriers Corp sold 20,349 shares at 26.290USD and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

Gilat to Showcase Advanced Defense Connectivity Solutions at Satellite...

Gilat to Showcase Advanced Defense Connectivity Solutions at Satellite 2026 Gilat Defense empowers defense forces with integrated communications solutions built for mission‑critical operations PETAH TIKVA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that its defense division, Gilat Defense, will showcase a comprehensive suite of advanced defense‑grade connectivity technologies at Satellite 2026, taking place March 23-26 in Washington, D...

Marine Leleux ... (+3)
  • Marine Leleux
  • Maureen Schuller
  • Suvi Platerink Kosonen

Bank Brunch/Turmoil and AT1 spreads

AT1 spreads wider with the Middle East conflict

Fugro N.V.: 1 director

A director at Fugro N.V. bought 6,000 shares at 10.750EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Medline Inc. announces launch of secondary offering of Class A common ...

Medline Inc. announces launch of secondary offering of Class A common stock NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) have commenced an underwritten public offering of 75,000,000 shares of Medline’s Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”...

Equnico SE: 1 director

A director at Equnico SE sold 630,000 shares at 1.200PLN and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Immunocore to present at upcoming investor conferences

Immunocore to present at upcoming investor conferences Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 03 March 2026) , a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in March.         TD Cowen 46th Annual Healthcare Conference         Presentation: Tuesday, March 3, 2026, at 2:30 p.m. E...

 PRESS RELEASE

Aspo Plc - Managers' Transactions - Erkka Repo

Aspo Plc - Managers' Transactions - Erkka Repo Aspo Plc Managers’ transactions March 3, 2026 at 14.00 EET    Aspo Plc - Managers' Transactions - Erkka Repo____________________________________________Person subject to the notification requirementName: Erkka RepoPosition: Chief Financial OfficerIssuer: Aspo OyjLEI: 7437000TB0GHDHLPX677Notification type: INITIAL NOTIFICATIONReference number: 145229/4/4____________________________________________Transaction date: 2026-03-02Outside a trading venueInstrument type: SHAREISIN: FI0009008072Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE ...

 PRESS RELEASE

AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in...

AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression Aligned with FDA on dual-trial design Phase 3 program that aims to demonstrate robust efficacy and long-term safety and that allows for flexible dosingPhase 3 program initiation remains on track for Q2 2026BPL-003 was previously granted Breakthrough Therapy designation by the FDA for treatment-resistant depressionVirtual Investor Day scheduled on March 6, 2026, to provide further detail on the BPL-003 Phase 3 clinical strategy NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley In...

 PRESS RELEASE

Aspo Oyj - Johdon liiketoimet - Erkka Repo

Aspo Oyj - Johdon liiketoimet - Erkka Repo Aspo Oyj Johtohenkilöiden liiketoimet 3.3.2026 klo 14.00  Aspo Oyj - Johdon liiketoimet - Erkka Repo____________________________________________IlmoitusvelvollinenNimi: Erkka RepoAsema: TalousjohtajaLiikkeeseenlaskija: Aspo OyjLEI: 7437000TB0GHDHLPX677Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 145229/4/4____________________________________________Liiketoimen päivämäärä: 2026-03-02Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009008072Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINEN Liiketoimien yksityiskohtaiset tiedot(1): ...

 PRESS RELEASE

Aspo Plc - Managers' Transactions - Taru Uotila

Aspo Plc - Managers' Transactions - Taru Uotila Aspo Plc Managers’ transactions March 3, 2026 at 14.00 EET    Aspo Plc - Managers' Transactions - Taru Uotila____________________________________________Person subject to the notification requirementName: Taru UotilaPosition: Other senior managerIssuer: Aspo OyjLEI: 7437000TB0GHDHLPX677Notification type: INITIAL NOTIFICATIONReference number: 145277/6/4____________________________________________Transaction date: 2026-03-02Outside a trading venueInstrument type: SHAREISIN: FI0009008072Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE ...

 PRESS RELEASE

Strata Critical Medical Announces Fourth Quarter 2025 Results

Strata Critical Medical Announces Fourth Quarter 2025 Results Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata's organic growthFull year 2025 net loss from continuing operations was $20.1 millionFull year 2025 revenue and Adjusted EBITDA(1) of $197.1 million and $14.1 million, respectively, both beat the high end of our guidance rangeRaising full year 2026 revenue guidance to between $260 and $275 million and Adjusted EBITDA guidance to between $29 and $...

 PRESS RELEASE

Aspo Oyj - Johdon liiketoimet - Taru Uotila

Aspo Oyj - Johdon liiketoimet - Taru Uotila Aspo Oyj Johtohenkilöiden liiketoimet 3.3.2026 klo 14.00  Aspo Oyj - Johdon liiketoimet - Taru Uotila____________________________________________IlmoitusvelvollinenNimi: Taru UotilaAsema: Muu ylin johtoLiikkeeseenlaskija: Aspo OyjLEI: 7437000TB0GHDHLPX677Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 145277/6/4____________________________________________Liiketoimen päivämäärä: 2026-03-02Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009008072Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINEN Liiketoimien yksityiskohtaiset tiedot(...

 PRESS RELEASE

Aspo Plc - Managers' Transactions - Rolf Jansson

Aspo Plc - Managers' Transactions - Rolf Jansson Aspo Plc Managers’ transactions March 3, 2026 at 14.00 EET    Aspo Plc - Managers' Transactions - Rolf Jansson____________________________________________Person subject to the notification requirementName: Rolf JanssonPosition: Chief Executive OfficerIssuer: Aspo OyjLEI: 7437000TB0GHDHLPX677Notification type: INITIAL NOTIFICATIONReference number: 145079/6/6____________________________________________Transaction date: 2026-03-02Outside a trading venueInstrument type: SHAREISIN: FI0009008072Nature of transaction: RECEIPT OF A SHARE-BASED INCEN...

 PRESS RELEASE

Aclaris Therapeutics to Participate in the Leerink Partners 2026 Globa...

Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference WAYNE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Tuesday March 10, 2026, at 1:40 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink Partners 2026 Global Healthcare Conference in Miami, FL. A live a...

 PRESS RELEASE

OTC Markets Group Welcomes Golconda Gold Ltd. to OTCQX

OTC Markets Group Welcomes Golconda Gold Ltd. to OTCQX NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (TSX-V: GG; OTCQX: GGGOF), an unhedged gold producer, has qualified to trade on the OTCQX® Best Market. Golconda Gold Ltd. upgraded to OTCQX from the OTCQB® Venture Market. Golconda Gold Ltd. begins trading today on OTCQX under the symbol “GGGOF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . The OTCQX Market is desig...

 PRESS RELEASE

Sparklight Launches Mobile Service with Limited-Time Offer of One Free...

Sparklight Launches Mobile Service with Limited-Time Offer of One Free Unlimited Line for 12 Months No-contract prepaid plans start at $15 per month, with one unlimited line free for 12 months for eligible internet customers PHOENIX, March 03, 2026 (GLOBE NEWSWIRE) -- As reliable mobile connectivity becomes increasingly essential for education, work, healthcare access and everyday life, , a leading broadband communications provider serving more than 1 million customers across 24 states, has introduced , expanding affordable wireless options for customers and reinforcing the company’s co...

 PRESS RELEASE

HCI Group Authorizes $80 Million Stock Repurchase Program

HCI Group Authorizes $80 Million Stock Repurchase Program TAMPA, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- The board of directors of HCI Group, Inc. (NYSE:HCI) has authorized a program to repurchase up to $80 million of the company’s common shares, subject to market conditions. The program permits the company to repurchase shares for cash periodically in open market purchases, block transactions, privately negotiated transactions in accordance with applicable federal securities laws, or by other means, including through the use of trading programs intended to qualify under Rule 10b5-1 und...

 PRESS RELEASE

CECO Environmental Announces Upcoming Investor Conferences

CECO Environmental Announces Upcoming Investor Conferences ADDISON, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces that CECO management will participate at the following investor conferences: March 5, 2026 – Citadel SMID Cap Generalist Investor ConferenceMarch 24, 2026 – 38th Annual Roth ConferenceApril 9, 2026 – Gabelli Funds’ 12th Waste & Environmental Services Symposium The presentations will b...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch